APA (7th ed.) Citation

Liu, T., Xu, J., Xu, W., Bai, Y., Yan, W., & Yang, H. (2011). Fluorine-18 deoxyglucose Positron Emission Tomography, Magnetic Resonance Imaging and Bone Scintigraphy for the Diagnosis of Bone Metastases in Patients with Lung Cancer: Which One is the Best? – a Meta-analysis. Clinical Oncology, 23(5), 350. https://doi.org/10.1016/j.clon.2010.10.002

Chicago Style (17th ed.) Citation

Liu, Tao, Jun-Ying Xu, Wen Xu, Yong-Rui Bai, Wei-Li Yan, and Hui-Lin Yang. "Fluorine-18 Deoxyglucose Positron Emission Tomography, Magnetic Resonance Imaging and Bone Scintigraphy for the Diagnosis of Bone Metastases in Patients with Lung Cancer: Which One Is the Best? – a Meta-analysis." Clinical Oncology 23, no. 5 (2011): 350. https://doi.org/10.1016/j.clon.2010.10.002.

MLA (9th ed.) Citation

Liu, Tao, et al. "Fluorine-18 Deoxyglucose Positron Emission Tomography, Magnetic Resonance Imaging and Bone Scintigraphy for the Diagnosis of Bone Metastases in Patients with Lung Cancer: Which One Is the Best? – a Meta-analysis." Clinical Oncology, vol. 23, no. 5, 2011, p. 350, https://doi.org/10.1016/j.clon.2010.10.002.